Investment firm Zrosk buys 10% stake in Lagos-based drugmaker MeCure

  • 📰 PremiumTimesng
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 78%

South Africa News News

South Africa South Africa Latest News,South Africa South Africa Headlines

MeCure said the off-market deal was finalised, following clearance from the NGX.

How Ukraine’s Superhuman Centre is helping war heroes walk againThe paradox of declining optimism, By Bolutife OluwadeleDangote Refinery, MPR hike and matters arising, By Abdulhaleem RingimHow Ukraine’s Superhuman Centre is helping war heroes walk againThe paradox of declining optimism, By Bolutife OluwadeleDangote Refinery, MPR hike and matters arising, By Abdulhaleem RingimZrosk Investment Management Limited, a firm of investment managers focusing on Africa, has taken a 10 per cent ownership...

Balance sheet size as of June was N52.9 billion, while market value at the start of trade on Friday stood at N33.6 billion. “One of our core convictions at Zrosk IM is that ownership on the African continent is shifting towards indigenous hands. We view the stock market as a theatre of such transition, and we see MeCure Industries as a potential dominant player in the pharmaceutical value chain on the continent,” Samson Esemuede, Zrosk’s managing director, said.

At Premium Times, we firmly believe in the importance of high-quality journalism. Recognizing that not everyone can afford costly news subscriptions, we are dedicated to delivering meticulously researched, fact-checked news that remains freely accessible to all.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in ZA

South Africa South Africa Latest News, South Africa South Africa Headlines